Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q4 FY23 results · Jan–Mar 2023
Divi's Laboratories reported revenue from operations of ₹1,950.77 crore (down 22.5% from Q4 FY22) and net profit of ₹320.97 crore (down 64.1% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,950.77 | 2,518.44 | −22.5% | 1,707.68 | +14.2% |
| Other income | 66.15 | 52.39 | +26.3% | 114.25 | −42.1% |
| Total income | 2,016.92 | 2,570.83 | −21.5% | 1,821.93 | +10.7% |
| Profit before tax | 466.48 | 1,075.74 | −56.6% | 435.63 | +7.1% |
| Net profit for the period | 320.97 | 894.64 | −64.1% | 306.80 | +4.6% |
| EPS, basic (₹) | 12.09 | 33.70 | −64.1% | 11.56 | +4.6% |
| Net margin (%) | 16.5 | 35.5 | 18.0 |
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,908.17 | 2,495.03 | −23.5% | 1,689.83 | +12.9% |
| Other income | 66.15 | 50.51 | +31.0% | 116.34 | −43.1% |
| Total income | 1,974.32 | 2,545.54 | −22.4% | 1,806.17 | +9.3% |
| Profit before tax | 468.04 | 1,065.69 | −56.1% | 439.11 | +6.6% |
| Net profit for the period | 318.79 | 882.96 | −63.9% | 310.90 | +2.5% |
| EPS, basic (₹) | 12.01 | 33.26 | −63.9% | 11.71 | +2.6% |
| Net margin (%) | 16.7 | 35.4 | 18.4 |
Consolidated
- Filed with BSE
- 22 May 2023, 15:58 IST
- Board meeting
- 20 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 22 May 2023, 15:58 IST
- Board meeting
- 20 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE